GeneReach Biotechnology Statistics

Total Valuation

TPEX:4171 has a market cap or net worth of TWD 1.31 billion. The enterprise value is 1.12 billion.

Market Cap	1.31B
Enterprise Value	1.12B

Important Dates

The next estimated earnings date is Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:4171 has 57.46 million shares outstanding.

Current Share Class	57.46M
Shares Outstanding	57.46M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	5.31%
Owned by Institutions (%)	0.49%
Float	42.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.14
PB Ratio	1.83
P/TBV Ratio	1.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.33
EV / Sales	5.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-37.72

Financial Position

The company has a current ratio of 2.50, with a Debt / Equity ratio of 0.37.

Current Ratio	2.50
Quick Ratio	2.12
Debt / Equity	0.37
Debt / EBITDA	n/a
Debt / FCF	-8.83
Interest Coverage	-17.10

Financial Efficiency

Return on equity (ROE) is -14.55% and return on invested capital (ROIC) is -6.47%.

Return on Equity (ROE)	-14.55%
Return on Assets (ROA)	-6.09%
Return on Invested Capital (ROIC)	-6.47%
Return on Capital Employed (ROCE)	-13.41%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.19
Inventory Turnover	1.71

Taxes

In the past 12 months, TPEX:4171 has paid 6.70 million in taxes.

Income Tax	6.70M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.39% in the last 52 weeks. The beta is 0.16, so TPEX:4171's price volatility has been lower than the market average.

Beta (5Y)	0.16
52-Week Price Change	-36.39%
50-Day Moving Average	21.22
200-Day Moving Average	26.81
Relative Strength Index (RSI)	48.51
Average Volume (20 Days)	609,771

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4171 had revenue of TWD 213.05 million and -108.81 million in losses. Loss per share was -1.90.

Revenue	213.05M
Gross Profit	131.16M
Operating Income	-109.00M
Pretax Income	-106.65M
Net Income	-108.81M
EBITDA	-49.41M
EBIT	-109.00M
Loss Per Share	-1.90

Full Income Statement

Balance Sheet

The company has 458.52 million in cash and 262.91 million in debt, giving a net cash position of 195.61 million or 3.40 per share.

Cash & Cash Equivalents	458.52M
Total Debt	262.91M
Net Cash	195.61M
Net Cash Per Share	3.40
Equity (Book Value)	715.41M
Book Value Per Share	12.24
Working Capital	355.75M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -23.34 million and capital expenditures -6.44 million, giving a free cash flow of -29.79 million.

Operating Cash Flow	-23.34M
Capital Expenditures	-6.44M
Free Cash Flow	-29.79M
FCF Per Share	-0.52

Full Cash Flow Statement

Margins

Gross margin is 61.56%, with operating and profit margins of -51.16% and -51.07%.

Gross Margin	61.56%
Operating Margin	-51.16%
Pretax Margin	-50.06%
Profit Margin	-51.07%
EBITDA Margin	-23.19%
EBIT Margin	-51.16%
FCF Margin	n/a

Dividends & Yields

TPEX:4171 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-8.32%
FCF Yield	-2.28%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 28, 2023. It was a forward split with a ratio of 1.25.

Last Split Date	Jul 28, 2023
Split Type	Forward
Split Ratio	1.25

Scores

TPEX:4171 has an Altman Z-Score of 3.38 and a Piotroski F-Score of 3.

Altman Z-Score	3.38
Piotroski F-Score	3